glp-1 agonists microdose Microdosing GLP-1s: A complete guide to risks, benefits, and protocols THE PCCA BLOG | Microdosing

Typical doses range from 250-1000 mg daily, though clinical evidence supports only modest benefits at lower doses

Particularly relevant for patients using semaglutide for type 2 diabetes management alongside weight loss

Studies measuring biochemical markers of muscle damage reveal that L-Carnitine reduces myoglobin levels immediately post-exercise (weighted mean difference: -11.55 ng/mL, p=0.04) and at 30-60 minutes (weighted mean difference: -41.09 ng/mL, p=0.001), as well as creatine kinase (CK) at 2 hours (weighted mean difference: -26.72 IU/L, p=0.02) and 24 hours (weighted mean difference: -48.72 IU/L, p=0.006) following exercise

Low levels are linked to chronic diseases like diabetes and heart disease

I do think the high folate w/ the (absent?) B12 is suspicious

The muscle-specific microRNA miR-1 regulates cardiac arrhythmogenic potential by targeting GJA1 and KCNJ2